The secret ingredient to healing? Your patient.
Aurix® is a breakthrough wound care solution that starts and ends with the patient. A biodynamic hematogel that harnesses a patient's innate healing mechanisms to jumpstart the natural repair process.
- Visible Results in Days, Not Weeks
- Broad treatment flexibility across patient profiles
- 5-8 minute point-of-care preparation
Safe, Rapid and Effective Point-of-Care Preparation
Aurix gel is derived from a patient's own platelets and plasma. Once applied, Aurix goes to work stimulating the body's natural ability to form new tissue, fill in wound defects and reduce wound volume.
Treatment Process
The Aurix System is used at point-of-care for the safe and rapid preparation of biodynamic hematogel from a small sample of a patient's own blood. Product preparation and application can be completed in less than 10 minutes using four rapid and easy steps.
Draw It
Take a small amount of the patient's blood.
Spin It
Use the Aurix System centrifuge to separate the platelets (1 minute spin).
Mix It
Mix with additives supplied by the Aurix Reagent Kit to produce a golden biodynamic gel.
Apply It
Apply over the entire wound, starting with tunnels and undermining, and cover with a clear dressing.
Demonstrated Clinical Efficacy
Aurix has a 96.5% positive response rate in all types of chronic wounds. It is the only therapy of its kind that is FDA-cleared for use on ulcers and wounds of all types.
FDA Clearance & Indications
The Aurix System is the only platelet-based system to produce a proprietary biodynamic gel formulation that is FDA-cleared for wound management. Suitable for exuding wounds and management of mechanically and surgically debrided wounds.
- Stalled or difficult-to-manage wounds
- Full or partial thickness wounds
- Exposed bone or tendon
- Undermining, sinus tracks, or tunnels
- Diabetic ulcers
- Venous ulcers
- Stage IV pressure injuries
Aurix Clinical Case Studies
BKA Dehiscence with Sinus Tract
46 year-old male. Previous treatments including VAC showed signs of regression. Received 3 Aurix treatments over 10 days.
Wound Volume Reduced 95.3%
Extensive Exposed Fascia and Tendon
89 year-old female with full thickness left anterior tibial ulcer. Exposed fascia, tendon, and muscle. Received one Aurix treatment.
Volume Reduced 59.2% by Day 7
Right Ischial Pressure Injury
SCI Patient with 2 year wound duration. Treated successfully with Aurix after prior failures.
Healed in 1 Month